Next Article in Journal
PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics
Previous Article in Journal
Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction
 
 
Review

Article Versions Notes

Cancers 2019, 11(7), 948; https://doi.org/10.3390/cancers11070948
Action Date Notes Link
article xml file uploaded 5 July 2019 12:52 CEST Original file -
article xml uploaded. 5 July 2019 12:52 CEST Update https://www.mdpi.com/2072-6694/11/7/948/xml
article pdf uploaded. 5 July 2019 12:52 CEST Version of Record https://www.mdpi.com/2072-6694/11/7/948/pdf
article html file updated 5 July 2019 23:26 CEST Original file -
article html file updated 2 August 2019 13:05 CEST Update -
article html file updated 13 February 2020 00:27 CET Update -
article html file updated 20 July 2022 07:27 CEST Update https://www.mdpi.com/2072-6694/11/7/948/html
Back to TopTop